Table II.
Testosterone levels.
| 21th day | At the end of the study | |||
|---|---|---|---|---|
| Factor | Median (IQR) | Differences from shama | Median (IQR) | Differences from 21th dayb |
| Groups | ||||
| Sham (n=9) | 1.07 (1.04) | 1.22 (0.66) | Z=0.415; P=0.678 | |
| PCOS control (n=9) | 4.40 (0.61) | Z=3.474; P=0.003 | 4.88 (0.65) | Z=2.547; P=0.011 |
| Merformin (n=8) | 4.35 (0.95) | Z=2.821; P=0.015 | 1.67 (0.36) | Z=2.521; P=0.012 |
| Metformin + PDE 4 inhibitor (n=10) | 4.69 (1.85) | Z=4.109; P<0.001 | 1.05 (0.22) | Z=2.803; P=0.005 |
| Comparisons of the groupsc | χ2=19.533; P<0.001 | χ2=27.057; P<0.001 | ||
a
Bonferroni corrected Mann-Whitney test results.
b
Wilcoxon signed rank test results.
c
Kruskal-Wallis non-parametric analyzing of variance test results. PCOS, polycystic ovary syndrome; PDE4i, phosphodiesterase 4 inhibitor; IQR, interquartile range.